← FDA Drug Approvals (Drugs@FDA)

CLIGAVYX

NDA · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2019-08-19

Drug application

FDA Application #

NDA210063

Application type

New Drug Application

Brand name

CLIGAVYX

Generic name

Fulvestrant

Active ingredients

FULVESTRANT

Dosage form

SOLUTION

Route

INTRAMUSCULAR

Marketing status

Discontinued

Sponsor

AVYXA HOLDINGS

First approval

2019-08-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown